News Roundup: TherapeuticsMD, Inc. (NASDAQ:TXMD), Senseonics Holdings, Inc. (NYSE:SENS)


TherapeuticsMD, Inc. (NASDAQ:TXMD)

TherapeuticsMD, Inc. (NASDAQ:TXMD) represented a move of -3.53 percent or $0.29 per share and closed its previous day trading session at $5.19. 2.35 Million Shares were traded in the last trading session with an Average Volume of 2.6 Million Shares. The stock currently has a Market Capitalization of 1.23 Billion.

TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. TherapeuticsMD, Inc. is based in Boca Raton, Florida.

The stock traded between $4.34 and $7.66 over 1-Year time period showing its price to sales ratio of 76.37. TherapeuticsMD, Inc. (NASDAQ:TXMD) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.

Right now, the stock has a 50-Day Simple Moving Average of $-13.71 and 200-Day Simple Moving Average of $-12.37. Its Price to Free Cash Flow is 0 and Price to Book of 14.42.

Analyst’s recommended the stock as 1.6 where 1 represents Strong Buy and 5 represents Sell.

In the last Quarter, TherapeuticsMD, Inc. (NASDAQ:TXMD) reported its Actual EPS of $-0.15/share. The analysts offering Earnings Estimates for the company were believing that TherapeuticsMD, Inc. could bring EPS of $-0.12/share. The difference between Actual EPS and Estimated EPS was -0.03 Percent. Thus showing an Earnings Surprise of -25 Percent.

Senseonics Holdings, Inc. (NYSE:SENS)

In the last trading session, Senseonics Holdings, Inc. (NYSE:SENS) added its value by -5.42% closing at the price of $3.84. The stock currently has market capitalization of 690.89 Million, with average volume of 1.96 Million shares.

Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Senseonics Holdings, Inc. (NYSE:SENS) is showing beta of 0. This particular value of beta suggests that Senseonics Holdings, Inc. (NYSE:SENS) has historically moved 0% for every 100% move in the benchmark, based on price level.

EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Senseonics Holdings, Inc. (NYSE:SENS) is at $-0.65.

The stock currently has RSI of 49.9. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.

Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States.

Senseonics Holdings, Inc. (NYSE:SENS) topped its 52-week high price of $5.29 on 06/22/18 and 52-Week Low Price of $2.41 on 02/09/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 8.20% and monthly volatility of 7.19% respectively.